DMARDs and the JAK Inhibitors have improved RA treatment. But not many new drugs are in the offing at the moment.
Humira successor indicated for adults with inadequate response or intolerance to methotrexate.
A Canadian study has exciting findings about offspring exposed to tumor necrosis factors.
High-cost treatments for rheumatoid arthritis has fueled the need to better understand their value to healthcare systems and patients.